Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fulminant hepatic failure in chronic hepatitis B on withdrawal of corticosteroids, azathioprine and infliximab for Crohn's disease.

× No keyword cloud information.

13 in total

Review 1. Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors: D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal: Can J Gastroenterol Date: 2009-03 Impact factor: 3.522

Review 2. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors: Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal: World J Hepatol Date: 2015-03-27

Review 3. Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.

Authors: H Matthew Cohn; Maneesh Dave; Edward V Loftus
Journal: Inflamm Bowel Dis Date: 2017-08 Impact factor: 5.325

Review 4. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors: María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal: World J Gastroenterol Date: 2013-11-14 Impact factor: 5.742

Review 5. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action.

Authors: Matthew B Carroll; Michael A Forgione
Journal: Clin Rheumatol Date: 2010-06-16 Impact factor: 2.980

Review 6. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.

Authors: María Luisa Manzano-Alonso; Gregorio Castellano-Tortajada
Journal: World J Gastroenterol Date: 2011-03-28 Impact factor: 5.742

Review 7. Optimizing the safety of biologic therapy for IBD.

Authors: Shanika de Silva; Shane Devlin; Remo Panaccione
Journal: Nat Rev Gastroenterol Hepatol Date: 2010-02 Impact factor: 46.802

Review 8. Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors: Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal: World J Gastroenterol Date: 2013-03-07 Impact factor: 5.742

9. Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China.

Authors: Yao He; Pingping Xu; Yujun Chen; Rongping Yang; Baili Chen; Zhirong Zeng; Minhu Chen
Journal: Int J Clin Exp Med Date: 2015-05-15

Review 10. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

Authors: Stefano Sansone; Maria Guarino; Fabiana Castiglione; Antonio Rispo; Francesco Auriemma; Ilaria Loperto; Matilde Rea; Nicola Caporaso; Filomena Morisco
Journal: World J Gastroenterol Date: 2014-04-07 Impact factor: 5.742